1. Pulmonary arterial hypertension (PAH) | 1.1 Idiopathic |
1.2 Heritable | |
1.3 Drugs and toxins induced | |
1.4 Associated with (APAH): | |
  1.4.1 Connective tissue disease | |
  1.4.2 Infection with human immunodeficiency virus | |
  1.4.3 Portal hypertension | |
  1.4.4 Congenital heart disease | |
  1.4.5 Schistosomiasis | |
  1.4.6 Chronic haemolytic anaemia | |
1.5 Persistent pulmonary hypertension of the newborn | |
2. Pulmonary hypertension with left heart disease | 2.1 Systolic dysfunction |
2.2 Diastolic dysfunction | |
2.3 Valvular disease | |
3. Pulmonary hypertension due to lung diseases and/or hypoxia | 3.1 Chronic obstructive pulmonary disease |
3.2 Interstitial lung disease | |
3.3 Other pulmonary diseases with mixed restrictive and obstructive pattern | |
3.4 Sleep-disordered breathing | |
3.5 Alveolar hypoventilation disorders | |
3.6 Chronic exposure to high altitude | |
3.7 Developmental abnormalities | |
4. Chronic thromboembolic pulmonary hypertension | Â |
5. PH with unclear and/or multifactorial mechanisms | 5.1 Haematological disorders: myeloproliferative disorders, splenectomy. |
5.2 Systemic disorders: sarcoidosis, pulmonary Langerhans cell histiocytosis, lymphangioleiomyomatosis, neurofibromatosis, vasculitis | |
5.3 Metabolic disorders: glycogen storage disease, Gaucher disease, thyroid disorders | |
5.4 Others: tumoral obstruction, fibrosing mediastinitis, chronic renal failure on dialysis |